Cargando…
Oral fluoropyrimidines among the new drugs for patients with metastatic breast cancer
Although drugs such as the taxoids and vinorelbine have increased the options available for anthracycline-resistant metastatic breast cancer, new therapeutic options are needed, particularly for taxoid-refractory tumours. Increasing emphasis is being placed on the development of oral agents, which m...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2001
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363663/ https://www.ncbi.nlm.nih.gov/pubmed/11384089 http://dx.doi.org/10.1054/bjoc.2001.1819 |